Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kodiak Sciences Inc (NQ: KOD )

6.510 +0.320 (+5.17%)
Streaming Delayed Price Updated: 11:39 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kodiak Sciences Inc

< Previous 1 2 3 4 Next >
Mid-Morning Market Update: U.S. Stocks Open Higher; Lowe's Tops Q4 Expectations
U.S. stocks opened higher this morning after recording sharp losses on Tuesday. US President Biden late Tuesday announced sanctions on some Russian banks and individuals.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
Read Why Barclays Analyst Is 'Negatively Biased' On Kodiak Sciences
Barclays has lowered the firm's price target on Kodiak Sciences Inc (NASDAQ: KOD 
Via Benzinga
What 4 Analyst Ratings Have To Say About Kodiak Sciences
Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings: 
Via Benzinga
Why Kodiak Sciences Shares Are Plunging Today
Kodiak Sciences Inc (NASDAQ: KOD) has announced topline results from its Phase 2b/3 trial evaluating KSI-301 in treatment-naïve subjects with neovascular (wet) age-... 
Via Benzinga
Executives Buy Around $500M Of 4 Stocks
US stocks traded lower on Friday after recording sharp losses on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher; Alphabet Tops Q4 Views
Pre-open movers 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
3 Stocks Insiders Are Buying: Kodiak Sciences, EverQuote And More
Crude oil prices traded higher on Wednesday after gaining close to 3% in the prior session, as the API reported that US crude stockpiles dropped by... 
Via Benzinga
Last Week's Notable Insider Buys Included Evergy, Frontier Communications And More
Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain. The week's most notable insider buys were at an REIT, a... 
Via Benzinga
52 Weeks High And Low Article
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x... 
Via Benzinga
The Past Week's Notable Insider Buys: Continental Resources, Oscar Health, And More
With earnings-reporting season over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week. 
Via Talk Markets
The Past Week's Notable Insider Buys: Continental Resources, Oscar Health And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The week's most notable insider buys were at a health... 
Via Benzinga
The Past Week's Notable Insider Buys: Chipotle, Krispy Kreme, Petco Health And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window... 
Via Benzinga
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
The Past Week's Notable Insider Buys Include AppLovin, Cricut, Biotechs, And More
With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week. 
Via Talk Markets
The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window... 
Via Benzinga
4 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
The Past Week's Notable Insider Buys: ConocoPhillips, Cricut, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some energy companies, including a supermajor, have seen... 
Via Benzinga
Is This Mid-Cap Biotech Stock a Buy Now?
This mid-cap growth stock could be a long-term winner. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Kodiak Sciences Has Declined $125M Funding From Baker Bros Citing Strong Balance Sheet
In December 2019, Kodiak Sciences Inc (NASDAQ: KOD) entered into a funding agreement with Baker Bros Advisors LP, wherein Baker Bros agreed to fund up to $225... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
Why Kodiak Sciences Stock Is Tumbling Today
The company provided a first-quarter update with news that it's launching another late-stage clinical study of its lead candidate. 
Via The Motley Fool
40 Stocks Moving In Monday's Mid-Day Session
Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-average news. Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 35% to $2.97. Cue... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.